Amgen, Kite Pharma in Immunotherapy Pact

Amgen and Kite Pharma reached a research collaboration and license agreement to develop cancer immunotherapy treatments.



from WSJ.com: US Business http://ift.tt/1xL3Oce

via IFTTT